Short answer
aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on March 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results announced March 5, 2026: details in Exhibit 99.1.
aTYR PHARMA INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results announced March 5, 2026: details in Exhibit 99.1
- As a clinical-stage biopharma, key metrics to watch: cash runway, R&D spend, and any pipeline milestones cited in the release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other aTYR PHARMA INC 8-K filings
Get the next ATYR 8-K as it lands
Follow ATYR for push alerts, or ask the research agent what this filing means.